Wilson Sonsini Goodrich & Rosati represented trade association Computer & Communications Industry Association in the matter. On July 1, 2024, the U.S. Supreme Court decided Moody...
Moody v. NetChoice, LLC
Sunrun’s $886.3 Million Senior Securitization of Residential Solar and Battery Systems
Wilson Sonsini Goodrich & Rosati advised Sunrun on the deal. Sunrun (Nasdaq: RUN) announced it has priced a securitization of leases and power purchase agreements. The...
Baiwang Cloud’s IPO and SEHK Listing
Wilson Sonsini Goodrich & Rosati acted as Baiwang Cloud’s U.S. and Hong Kong counsel in the IPO and SEHK listing. Baiwang Co., Ltd. (Baiwang Cloud), an...
Radionetics’ Strategic Agreement with Eli Lilly
Cooley advised Radionetics Oncology on the transaction, and Wilson Sonsini Goodrich & Rosati acted as patent counsel for Radionetics Oncology and advised the company on patent....
Dida’s IPO and SEHK Listing
Wilson Sonsini Goodrich & Rosati acted as Dida’s U.S. and Hong Kong counsel in the IPO and SEHK listing. China ride-sharing app operator Dida Inc. (Dida)...
Nokia’s Acquisition of Infinera
Skadden, Arps, Slate, Meagher & Flom LLP and Roschier advised Nokia on the transaction, and Wilson Sonsini Goodrich & Rosati advised Infinera. Nokia (NYSE: NOK) and...
Nubank’s Acquisition of Hyperplane
Wilson Sonsini Goodrich & Rosati advised Hyperplane on the transaction. Brazil-based Nubank (NU) announced it has agreed to acquire Hyperplane, a data intelligence company from Silicon...
Entrata’s Acquisition of Colleen AI
Wilson Sonsini Goodrich & Rosati represented Entrata in the transaction, and Goldfarb Gross Seligman represented Colleen AI. Entrata®, a leading AI-enabled multifamily Operating System (OS), announced...
Boston Scientific’s $1.26 Billion Acquisition of Silk Road
Latham & Watkins represented Boston Scientific Corporation in the transaction, and Wilson Sonsini Goodrich & Rosati represented Silk Road Medical. Boston Scientific Corporation (“Boston Scientific”) (NYSE:...
Takeda’s $75 Million Investment in Ascentage Pharma
Wilson Sonsini Goodrich & Rosati acted as the U.S. and Hong Kong counsel to Ascentage Pharma in the transaction. Ascentage Pharma Group International (Ascentage Pharma) (6855.HK)...
SewerAI’s $15 Million Series B Financing Round
Wilson Sonsini Goodrich & Rosati advised SewerAI on the transaction. SewerAI, a global leader in AI and cloud-driven sewer condition assessment, announced the completion of a...
Talkiatry’s $130 Million Series C Financing Round
Wilson Sonsini Goodrich & Rosati advised a16z on the transaction. Talkiatry, a leading provider of high-quality, in-network psychiatric care, announced the completion of a $130 million...